Top Markets
Coin of the day
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
株式のランク #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
株価
$93.80
最終同期: 2025-04-28
時価総額
$2.68B
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Aerovate Therapeutics, Inc. (AVTE)

カテゴリー

Aerovate Therapeutics, Inc.(AVTE)のEPS
June 2026 時点のEPS TTM: $-3.65K
Aerovate Therapeutics, Inc.の最新の財務報告と株価によると、同社の現在のEPS(TTM)は$-3.65Kです。2023年末には、EPSは$-2.87で、2022年のEPS$-2.10と増加でした。
Aerovate Therapeutics, Inc.のEPS履歴(2019から2026まで)
各年末時点のEPS
EPS 変化
2026 (TTM) $-3.65K 149,412.70%
2024 $-2.44 -14.98%
2023 $-2.87 36.67%
2022 $-2.10 12.30%
2021 $-1.87 -95.34%
2020 $-40.17 28,592.86%
2019 $-0.14 0.00%
同様の企業または競合他社のEPS
企業 EPS EPSの差
$17.32 -100.47%
US
$27.74 -100.76%
NL
$-7.98 -99.78%
US
$-5.29 -99.85%
AU
- -
CH